Association of a CAV-1 haplotype to familial aggressive prostate cancer

Prostate

Volumn 65, Issue 2, 2005, Pages 171-177

  Haeusler, Juergen ^a   Hoegel, Josef ^a   Bachmann, Natascha ^a   Herkommer, Kathleen ^a   Paiss, Thomas ^a   Vogel, Walther ^a   Maier, Christiane ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Case control study; CAV 1; DNA polymorphism; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CAV 1 GENE; CHROMOSOME 7Q; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL CANCER; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; CASE-CONTROL STUDIES; CAVEOLIN 1; CAVEOLINS; DNA MUTATIONAL ANALYSIS; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 25444458079     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20256     Document Type: Article

References (26)

1. Brawley OW, Giovannucci E, Kramer BS. Epidemiology of prostate cancer. In: Vogelzang SP, Shipley WU, Coffey DS, editors. Comprehensive textbook of genitourinary oncology. Philadelphia: Lippincott Williams and Wilkins; 2000. pp 533-544.
2. Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res 1995;1:1385-1389.
3. Alers JC, Krijtenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schroder FH, van der Kwast TH, Bosman FT, van Dekken H. Interphase cytogenetics of prostatic tumor progression: Specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 1997;77:437-448.
4. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998;153:141-148.
5. Cui J, Deubler DA, Rohr LR, Zhu XL, Maxwell TM, Changus JE, Brothman AR. Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization. Cancer Genet Cytogenet 1998;107:51-60.
6. Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C, Tanke HJ, Schroder FH, van Dekken H. Identification of genetic markers for prostatic cancer progression. Lab Invest 2000;80:931-942.
7. Tobias ES, Hurlstone AF, MacKenzie E, McFarlane R, Black DM. The TES gene at 7q31.1 is methylated in tumors and encodes a novel growth suppressing LIM domain protein. Oncogene 2001; 20:2844-2853.
8. Zenklusen JC, Conti CJ, Green ED. Mutational and functional analyses reveal that ST7 is a highly conserved tumor suppressor gene on human chromosome 7q31. Nat Genet 2001;27:392-398.
9. Chene L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int J Cancer 2004;111:798-804.
10. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 1995;55(18): 4114-4119.
11. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ. Genome-wide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67(1):92-99.
12. Paiss T, Woerner S, Kurtz F, Haeussler J, Hautmann RE, Gschwend JE, Herkommer K, Vogel W. Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur J Hum Genet 2003;11(1):17-22.
13. Hatanaka M, Maeda T, Ikemoto T, Mori H, Seya T, Shimizu A. Expression of caveolin-1 in human T cell leukemia cell lines. Biochem Biophys Res Commun 1998;253(2):382-387.
14. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998;16(11):1391-1397.
15. Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenity. Cancer Res 2000;60(20):5870-5878.
16. Bagnoli M, Tomassetti A, Figini M, Flati S, Dolo V, Canevari S, Miotti S. Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression. Oncogene 2000;19(41):4754-4763.
17. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R. Caveolin-1 expression in advanced-stage ovarian carcinoma-a clinicopathologic study. Gynecol Oncol 2001;81(2):166-171.
18. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, Schneider U. Down-regulation of caveolin-1: A candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001;158(3):833-839.
19. Racine C, Belanger M, Hirabayashi H, Boucher M, Chakir J, Couet J. Reduction of caveolin-1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun 1999;255(3): 580-586.
20. Glenney JR Jr, Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 1992;89(21):10517-10521.
21. Li WP, Liu P, Pilcher BK, Anderson RG. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 2001;114:1397-1408.
22. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 1998;4:1873-1880.
23. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J, Thompson TC. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 1998;4:1062-1064.
24. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 1999;59:5719-5723.
25. Paiss T, Herkommer K, Chab A, Haeussler J, Vogel W, Gschwend JE, Hautmann RE. Familial prostate carcinoma in Germany. Urologe A 2002;41:38-43.
26. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004;27(1): 21-32.